Skip to main content
Log in

Denosumab may stabilise pain, maintain HRQOL in MM

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Chung KC, Barlev A, Qian Y, Jun S.Pain and health-related quality of life in patients with relapsed and plateau-phase multiple myeloma treated with denosumab. 50th Annual Meeting and Exposition of the American Society of Hematology: abstr. 2388, 7 Dec 2008. Available from: URL: http://www.hematology.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Denosumab may stabilise pain, maintain HRQOL in MM. Pharmacoecon. Outcomes News 571, 10 (2009). https://doi.org/10.2165/00151234-200905710-00024

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905710-00024

Keywords

Navigation